labetalol has been researched along with Urination Disorders in 3 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Urination Disorders: Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dosage ranged from 100 to 2400 mg per day (mean 654 mg per day) and treatment was continued for between 6 and 18 months (mean 7." | 1.27 | Side-effects with long-term labetalol: an open study of 251 patients in a single centre. ( Tcherdakoff, P, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tcherdakoff, P | 1 |
| Bailey, RR | 1 |
| O'Meara, J | 1 |
| White, WB | 1 |
3 other studies available for labetalol and Urination Disorders
| Article | Year |
|---|---|
Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
Topics: Adult; Aged; Asthma; Ethanolamines; Female; Humans; Hypertension; Hypotension, Orthostatic; Labetalo | 1983 |
Scalp tingling and difficulty in micturition in patients on labetalol.
Topics: Ethanolamines; Female; Humans; Hyperesthesia; Hypertension; Labetalol; Male; Middle Aged; Scalp; Uri | 1977 |
Ejaculatory failure and urinary dysfunction secondary to labetalol.
Topics: Adult; Ejaculation; Humans; Labetalol; Male; Middle Aged; Urination Disorders | 1988 |